Markets:

Overview

News

Currencies

International

Treasuries

Pacific Biosciences of California, Inc. - Common Stock (NQ:PACB)

2.265 -0.055 (-2.37%)

Streaming Delayed Price Updated: 12:02 PM EST, Dec 1, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pacific Biosciences of California, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Select Medical, Guardant Health, Artivion, PacBio, and Intuitive Surgical Shares Are Falling, What You Need To Know

September 10, 2025

A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading.

Via StockStory

Topics Economy Stocks

PacBio (PACB) Stock Trades Up, Here Is Why

August 22, 2025

Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 8.3% in the afternoon session after Federal Reserve Chair Jerome Powell opened the door to potential interest rate...

Via StockStory

Topics Economy Stocks

3 Russell 2000 Stocks Walking a Fine Line

August 14, 2025

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher...

Via StockStory

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

PacBio (PACB) Shares Skyrocket, What You Need To Know

August 13, 2025

Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 10.4% in the afternoon session after it received favorable reviews from Wall Street, with analysts raising their price...

Via StockStory

Topics Artificial Intelligence

The Analyst Verdict: Pacific Biosciences In The Eyes Of 4 Experts ↗

August 11, 2025

Via Benzinga

PACB Q2 Deep Dive: International Demand, Consumables Growth, and Clinical Adoption Drive Results

August 11, 2025

Genomics company Pacific Biosciences of California (NASDAQ:PACB) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 10.4% year on year to $39.77 million. Its non-GAAP...

Via StockStory

Topics World Trade

PacBio (PACB) Stock Trades Up, Here Is Why

August 08, 2025

Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 7.1% in the morning session after the company reported better-than-expected second-quarter 2025 financial results,...

Via StockStory

PACB Sales Up 11% ↗

August 07, 2025

Via The Motley Fool

PacBio (NASDAQ:PACB) Delivers Strong Q2 Numbers, Stock Soars

August 07, 2025

Genomics company Pacific Biosciences of California (NASDAQ:PACB) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 10.4% year on year to $39.77 million. Its non-GAAP...

Via StockStory

Topics Artificial Intelligence

PacBio (PACB) Q2 Earnings Report Preview: What To Look For

August 05, 2025

Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be announcing earnings results this Thursday afternoon. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence World Trade

PacBio, 10x Genomics, QuidelOrtho, STAAR Surgical, and Clover Health Stocks Trade Down, What You Need To Know

July 29, 2025

A number of stocks fell in the afternoon session after industry bellwether UnitedHealth Group (UNH) slashed its 2025 profit forecast after reporting a significant surge in medical costs, sending...

Via StockStory

3 Cash-Burning Stocks Walking a Fine Line

July 28, 2025

Companies that burn cash at a rapid pace can run into serious trouble if they fail to secure funding. Without a clear path to profitability, these businesses risk dilution, mounting debt, or even...

Via StockStory

Topics Bankruptcy

3 Low-Volatility Stocks We Steer Clear Of

July 24, 2025

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Via StockStory

Why PacBio (PACB) Stock Is Up Today

July 23, 2025

Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 7.4% in the afternoon session after the company announced it had joined the 1000 Genomes Long Read Sequencing Project,...

Via StockStory

Topics Government World Trade

1 Healthcare Stock to Keep an Eye On and 2 to Be Wary Of

July 07, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of...

Via StockStory

Topics Stocks

3 Unprofitable Stocks Walking a Fine Line

July 02, 2025

Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.

Via StockStory

Beyond The Numbers: 4 Analysts Discuss Pacific Biosciences Stock ↗

June 25, 2025

Via Benzinga

3 Stocks Under $10 with Open Questions

June 19, 2025

Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums). That doesn’t mean they’re bargains though, and we urge investors to be...

Via StockStory

The RealReal, Carnival, PacBio, Quest Resource, and Hudson Technologies Shares Are Soaring, What You Need To Know

June 16, 2025

A number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +1.5%, S&P 500 +1.0%) as reports pointed to easing tensions between Israel and Iran.

Via StockStory

Topics Artificial Intelligence Economy Stocks

12 Health Care Stocks Moving In Friday's After-Market Session ↗

June 13, 2025

Via Benzinga

PACB Q1 Earnings Call: Cost Reductions and Clinical Adoption Offset Market Headwinds

June 10, 2025

Genomics company Pacific Biosciences of California (NASDAQ:PACB) announced better-than-expected revenue in Q1 CY2025, but sales fell by 4.3% year on year to $37.15 million. Its non-GAAP loss of $0.15...

Via StockStory

Topics World Trade

Q1 Earnings Roundup: PacBio (NASDAQ:PACB) And The Rest Of The Life Sciences Tools & Services Segment

June 04, 2025

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at life sciences tools & services stocks,...

Via StockStory

Topics Artificial Intelligence

3 Out-of-Favor Stocks Skating on Thin Ice

May 26, 2025

The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whether they're witnessing fire sales or falling...

Via StockStory

Topics Supply Chain

Where Pacific Biosciences Stands With Analysts ↗

May 15, 2025

Via Benzinga

1 Russell 2000 Stock with Exciting Potential and 2 to Approach with Caution

May 14, 2025

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the...

Via StockStory

PacBio (NASDAQ:PACB) Beats Expectations in Strong Q1

May 08, 2025

Genomics company Pacific Biosciences of California (NASDAQ:PACB) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 4.3% year on year to $37.15 million. Its...

Via StockStory

PacBio (PACB) Q1 Earnings: What To Expect

May 07, 2025

Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be reporting results tomorrow after market close. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence

Cathie Wood Sells Palantir Shares Worth $2.65 Million Ahead Of Earnings, Doubles Down On This Chip Giant ↗

April 30, 2025

On Wednesday, April 30, 2025, Cathie Wood sold $2.65 million worth of Palantir shares through various ARK ETFs.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.